Clinical outcomes in t(11;14) multiple myeloma.

被引：0
|
作者：
Moustafa, Muhamad Alhaj
Rajkumar, S. Vincent
Dispenzieri, Angela
Lacy, Martha
Gertz, Morie A.
Buadi, Francis
Dingli, David
Hayman, Suzanne R.
Kapoor, Prashant
Hwa, Yi Lisa
Lust, John Anthony
Go, Ronald S.
Kyle, Robert A.
Kumar, Shaji
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8592
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes of Autologous Stem Cell Transplant (ASCT) in Patients with t (11;14) Multiple Myeloma(MM)
    Bumma, Naresh
    Zhao, Qiuhong
    Sharma, Nidhi
    Khan, Abdullah
    Chaudhry, Maria
    Benson, Don M.
    Efebera, Yvonne A.
    Devarakonda, Srinivas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S240 - S241
  • [22] Multiple myeloma with t(11;14): unique biology and evolving landscape
    Bal, Susan
    Kumar, Shaji K.
    Fonseca, Rafael
    Gay, Francesca
    Hungria, Vania Tm
    Dogan, Ahmet
    Costa, Luciano J.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 2950 - 2965
  • [23] Impact of t(11;14) in multiple myeloma on response to treatment and survival
    Puertas, Borja
    Sobejano, Eduardo
    Gomez, Sandra
    Hernandez, Alberto
    Alejo, Elena
    Alonso, David
    Maria Navarro, Jose
    Puerta, Carlos
    Garcia, Pablo
    Zapata, Evelyn
    Rey, Bea
    Redondo, Elena
    Gutierrez, Norma
    Puig, Noemi
    Garcia-Sanz, Ramon
    Mateos, Maria-Victoria
    Escalante, Fernando
    Gonzalez, Veronica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S119 - S119
  • [24] Multiple myeloma with t(11;14): impact of novel agents on outcome
    Puertas, Borja
    Gonzalez-Calle, Veronica
    Sobejano-Fuertes, Eduardo
    Escalante, Fernando
    Rey-Bua, Beatriz
    Padilla, Irene
    Garcia-Sanz, Ramon
    Puig, Noemi
    Gutierrez, Norma C. C.
    Mateos, Maria-Victoria
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [25] The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma
    Kleber, Martina
    Ntanasis-Stathopoulos, Ioannis
    Terpos, Evangelos
    CANCERS, 2023, 15 (24)
  • [26] Impact of t(11;14) in Multiple Myeloma on Response to Treatment and Survival
    Puertas, Borja
    Sobejano, Eduardo
    Gomez, Sandra
    Hernandez, Alberto
    Alejo, Elena
    Alonso, David
    Maria Navarro, Jose
    Puerta, Carlos
    Garcia, Pablo
    Zapata, Evelyn
    Redondo, Elena
    Rey, Beatriz
    Gutierrez, Norma
    Puig, Noemi
    Garcia-Sanz, Ramon
    Victoria Mateos, Maria
    Escalante, Fernando
    Gonzalez-Calle, Veronica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S413 - S414
  • [27] Multiple myeloma with t(11;14): impact of novel agents on outcome
    Borja Puertas
    Verónica González-Calle
    Eduardo Sobejano-Fuertes
    Fernando Escalante
    Beatriz Rey-Bua
    Irene Padilla
    Ramón García-Sanz
    Noemi Puig
    Norma C. Gutiérrez
    María-Victoria Mateos
    Blood Cancer Journal, 13
  • [28] Spontaneous tumoural regression in a patient with t(4;14) translocation multiple myeloma. A case report
    Puig, Noemi
    Chen, Christine
    Mikhael, Joseph
    Reece, Donna
    Trudel, Suzanne
    Kukreti, Vishal
    BLOOD, 2007, 110 (11) : 267B - 268B
  • [29] Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Takamatsu, Hiroyuki
    Yamashita, Takeshi
    Kurahashi, Shingo
    Saitoh, Takayuki
    Kondo, Tadakazu
    Maeda, Takeshi
    Nakazawa, Hideyuki
    Murata, Makoto
    Narita, Tomoko
    Kuroda, Junya
    Hashimoto, Hisako
    Kawamura, Koji
    Miyamoto, Toshihiro
    Honda, Sumihisa
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Sunami, Kazutaka
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03) : 474 - 479
  • [30] Efficacy of low dose thalidomide (T) in multiple myeloma.
    Durie, BGM
    Stepan, DE
    BLOOD, 1999, 94 (10) : 316A - 316A
12345